The Effects of a Recurrent Stroke Prevention Program on Blood Pressure, Low- density Lipoprotein Cholesterol, and Blood Glucose Among Patients with First Ischemic Stroke.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210318001

Enrollment

Registered

2021-03-18

Start date

2021-03-25

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke disease Ischemic stroke disease

Interventions

The intervention consists of 1. Four health behaviors education sessions (40 minutes/session) cover diet and limited salt diet for ischemic stroke, increasing physical activities, quit smoking and avo

Experimental Behavioral,No Intervention No treatment

A recurrent stroke prevention program,A standard care

Eligibility

Sex/Gender

All

Age

45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with first ischemic stroke by a neurologist via computed tomography or magnetic resonance imaging, 2. No cognitive impairment define as Thai Mental State Examination score 23 up, 3. No or minimal depression, no need to be treated, when completing the Thai version Patient Health Questionnaire with a score of fewer than 10 points, 4. Mild to moderate severity of stroke when completing the National Institute of Health Stroke Scale Thai version scores off less than 14, 5. Walking by themselves or use walking aids screen by the Modified Rankin score less than 4, 6. Performance in activities of daily living the Barthel Index Thai version scores 60 up, 7. No history of more serious medical diseases other than ischemic strokes, 8. Caregivers can join both educational sessions and during exercise, 9. Willing to participate in all activities throughout the study, and 10. Ability to use application line and have application line.

Exclusion criteria

Exclusion criteria: 1.Had active severe complications of ischemic stroke, hypertension, or diabetes mellites. 2. Had alteration of consciousness. 3. Cannot complete all phases of the study

Design outcomes

Primary

Measure	Time frame
BLOOD PRESSURE Baseline, week4, week8, week12 The standard sphygmomanometer ,LOW DENSITY LIPOPROTEIN CHOLESTEROL Baseline, week4, week8, week12 laboratory for measuring low-density lipoprotein cholesterol level ,BLOOD GLUCOSE Baseline, week4, week8, week12 laboratory for measuring blood glucose level	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactOrapin Jullmusi

Faculty of Nursing, Chulalongkorn University

orapinja0@gmail.com0626699451

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026